Related Experiment Video
Updated: Dec 15, 2025

11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.8K
A Case of HLA-DRB1-MET Rearranged Lung Adenocarcinoma With Rapid Response to Crizotinib
Siddharth Kunte1, James Stevenson1
1Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Clinical Lung Cancer
|July 14, 2020
Abstract
No abstract available in PubMed .
Keywords:
CrizotinibHLA-DRB1-MET rearrangementMET fusionsNon–small-cell lung cancerTargeted treatmentsMore Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.4K
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
9.1K